Last reviewed · How we verify
Antifungal treatment — Competitive Intelligence Brief
marketed
Antifungal agent (class varies by specific drug: azole, polyene, echinocandin, or other)
Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
Antifungal treatment (Antifungal treatment) — Hospices Civils de Lyon. Antifungal treatments work by disrupting fungal cell wall or membrane integrity, or inhibiting essential fungal enzymes, thereby killing or stopping the growth of fungal organisms.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Antifungal treatment TARGET | Antifungal treatment | Hospices Civils de Lyon | marketed | Antifungal agent (class varies by specific drug: azole, polyene, echinocandin, or other) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antifungal agent (class varies by specific drug: azole, polyene, echinocandin, or other) class)
- Hospices Civils de Lyon · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Antifungal treatment CI watch — RSS
- Antifungal treatment CI watch — Atom
- Antifungal treatment CI watch — JSON
- Antifungal treatment alone — RSS
- Whole Antifungal agent (class varies by specific drug: azole, polyene, echinocandin, or other) class — RSS
Cite this brief
Drug Landscape (2026). Antifungal treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/antifungal-treatment. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab